Precision Oncology - The Right Drug for the Right Patient
on August 26, 2018 at 2:40 pm
Nunn was a patient at the University of Alabama at Birmingham Comprehensive Cancer Center. He did not know it, but he was about to benefit from a new research program in precision oncology — using the genetic makeup of a patient’s tumor to determine the optimum therapy for that patient. “Precision
GlaxoSmithKline Is Acquiring a $300 Million Stake in 23andMe
by Bloomberg on July 26, 2018 at 3:24 am
GSK is acquiring a $300mm stake in 23andMe and revamping its approach to research.
Do fertility treatments bring higher risk of invasive breast or uterine cancer?
by By Dr. Stephanie Sophie Lee on July 19, 2018 at 2:45 pm
Fertility treatments come with repeated shots of hormones, but does that mean they also come with an increased risk of cancer? Not necessarily, according to a study published recently in the British Medical Journal. With assisted reproductive technology (ART), women are exposed to high levels of
Researchers develop new way to uncover hidden breast cancer tumors
on July 19, 2018 at 2:42 pm
Breast cancer is the most common form of cancer among women, accounting for 25 % of all cancer cases worldwide. Much progress has been made in detecting breast tumors, and survival rates are relatively high compared to other forms of cancer. However, some breast lesions have subtleties that are
Enzyme may get key role in drug design for breast cancer and brain condition
on July 2, 2018 at 7:35 pm
In recent years, researchers have focused on the enzyme TLK2, suspecting it of playing a main role in several diseases. A new study conducted at the University of Copenhagen now reveals that the enzyme exhibits lower levels of activity in intellectual disability and that it is possible to inhibit